Lariat Calixcrowns
1026±1034
a mixture of ethanol/H2O (20:1, 60 mL) was heated to reflux. After 15 ±
18 h, the solvent was removed under reduced pressure.
the reaction mixture was heated at reflux temperature for 12 h. After
removal of the solvent under vacuum, the residue was treated with CH2Cl2
(50 mL) and washed with H2O (2 Â 50 mL). The organic phase was
separated, and the solvent was distilled under vacuum.
25,27-Dimethoxy-p-tert-butylcalix[4]arene-26,28-(2-hydroxymethyl)-
crown-4 (27): The residue was treated with CH2Cl2/MeOH (10:1, 100 mL)
and filtered on celite. The solvents were distilled under vacuum to give a
white solid of the 1:1 complex between compound 27 and TsOH. Yield
70%; 1H NMR (400 MHz, CDCl3, 300 K): d 1.06 (s, 18H; C(CH3)3), 1.18,
1.19 (s, 9H; C(CH3)3), 2.04 (brs, 1H; OH), 2.30 (s, 3H; CH3Ar), 3.37 (d,
2J 12.8 Hz, 1H; Heq), 3.39 (d, 2J 12.2 Hz, 1H; Heq), 3.41 (d, 2J 12.7 Hz,
2H; Heq), 3.68 ± 4.70 (m, 17H; ArOCH2CHR(OCH2CH2)OAr, CH2OH;
25,27-Dimethoxy-p-tert-butylcalix[4]arene-26,28-[2-(2,2'-bipyridine-6-
methyl)oxy-methyl]crown-4 (2): Reverse-phase (C18) column chromatog-
raphy (elution gradient CH3OH/H2O, 15:1 ± CH3OH ± CH3OH/CH2Cl2,
20:1). Yield 66%; m.p. 113 ± 1158C; 1H NMR (CDCl3, 300 MHz, 300 K):
the spectrum was quite complex and demonstrated the presence of a
mixture of conformations. The following signals were assigned: bpy
multiplets at d 8.67, 8.36, 8.25, 7.77, 7.45, 7.30; OCH2(bpy) at d 4.77
(brs), 4.71(s); and the two singlets of the OCH3 protons at d 2.91 and
2.81; 13C NMR (75.5 MHz, CDCl3, 300 K): d 29.6 (t, ArCH2Ar c), 31.0,
31.2, 31.3, 31.4, 31.5, 31.6 (q, C(CH3)3), 33.8, 34.1 (s, C(CH3)3), 38.4, 38.8 (t,
ArCH2Ar pc, 1,3-alt), 57.7, 58.0, 58.5 (q, OCH3), 62.2 (q, OCH3), 68.2, 68.6,
69.4, 70.0, 70.3, 71.0, 71.2, 72.1, 73.0, 74.3, 74.5, 75.8 (t, CH2CHRO(CH2-
CH2O)2, CHCH2OCH2bpy), 77.4 (d, CHRO), 119.5, 119.7, 120.9 and 121.2
(d, bpy-3, bpy-3'), 123.6, 123.7, 124.7, 125.7, 125.9, 126.1, 126.2, 127.3 (d, m-
Ar, bpy-5, bpy-5'), 133.1, 133.3, 133.4, 133.5, 133.8, 133.9 (s, o-Ar), 136.9,
137.4 (d, bpy4, bpy-4'), 144.1, 144.4, 144.6 (s, p-Ar), 149.1, 149.2 (d, bpy-6'),
154.1, 154.2, 155.3, 155.4, 155.5 (s, i-Ar, bpy-2, bpy-2', bpy-6); MS (CI, CH4):
3
Hax), 6.92 ± 7.25 (m, 10H; Ar-H), 7.81 (d, J 8.0 Hz, 2H; TsH); 13C NMR
(75.5 MHz, CDCl3, 300 K): d 21.2 (q, TsCH3), 30.0, 30.3, 30.4, 31.1, 31.3,
31.4 (q, C(CH3)3; t, ArCH2Ar), 34.0, 34.1, 34.2 (s, C(CH3)3), 59.7, 64.0, 64.1
(q, OCH3), 67.8, 70.0, 71.0, 73.7, 76.4 (t, CH2CHR(OCH2CH2)2), 80.0 (d,
CHRO), 125.7, 125.8, 126.1, 126.2 (d, m-Ar), 128.6 (d, Ts) 133.7, 133.8,
134.0, 134.3, 134.4, 134.5 (s, o-Ar), 138.7 (s, Ts), 147.9, 148.1, 148.4 (s, p-Ar),
149.6, 149.7, 155.0 (s, i-Ar); MS (CI, CH4): m/z (%): 821.3 (100) [MH] ;
C53H72O7 ´ C7H8O3S (993.35): calcd C 72.55, H 8.12; found C 72.40, H 7.99.
25,27-Dimethoxy-p-tert-butylcalix[4]arene-26,28-(2-hydroxymethyl)-
crown-5 (28): Pure compound 28 was obtained by column chromatography
(SiO2, CHCl3/MeOH, 95:5). Yield 71%; m.p. 277 ± 2798C; 1H NMR
(300 MHz, CDCl3, 300 K): d 0.88 (s, 9H; C(CH3)3), 0.92 (s, 9H;
C(CH3)3), 1.25 (s, 9H; C(CH3)3), 1.26 (s, 9H; C(CH3)3), 2.00 (brs, 1H;
m/z (%): 990.2 (100) [MH] ; C64H80N2O7 (989.35): calcd C 77.70, H 8.15,
N 2.83; found C 77.83, H 8.25, N 2.76. A simpler 1H NMR spectrum can be
obtained by converting compound 2 into its 1:1 NaSCN complex (mainly in
the cone structure), by stirring a solution of 2 in CDCl3 with solid NaSCN
for 1 night. 2-NaSCN: 1H NMR (300 MHz, CDCl3, 300 K, NaSCN
complex): d 1.04, 1.13, 1.19, 1.20 (s, 9H; C(CH3)3), 3.35 ± 3.85, 4.15 ± 4.80
(m, 21H; Heq, ArOCH2CHRO(CH2CH2O)2, CHCH2, Hax), 3.99, 4.03 (s,
3H; OCH3), 4.79 (s, 2H; OCH2bpy), 6.98 ± 7.24 (m, 8H; Ar-H), 7.27 (m,
1H; bpy-5'-H), 7.43 (d, 3J 7.7 Hz, 1H; bpy-5-H), 7.75 (ddd, 3J 7.5 Hz,
3J 7.5 Hz, 4J 1.8 Hz, 1H; bpy-4'-H), 7.85 (dd, 3J 7.7 Hz, 3J 7.7 Hz,
1H; bpy-4-H), 8.28 (d, 3J 7.5 Hz, 1H; bpy-3'-H), 8.37 (d, 3J 7.7 Hz, 1H;
2
OH), 3.14, 3.17 (d, J 11.0 Hz, 2H; Heq), 3.53 ± 4.37 (m, 27H; ArOCH2-
CHR(OCH2CH2)3OAr, OCH3, CH2OH; Hax), 6.58 (s, 2H; Ar-H), 6.63 (s,
2H; Ar-H), 7.01 (s, 2H; Ar-H), 7.02 (s, 2H; Ar-H); 13C NMR (75.5 MHz,
CDCl3, 300 K): d 31.2, 31.7 (q, C(CH3)3; t, ArCH2Ar), 33.6, 34.1 (s,
C(CH3)3), 60.9, 61.3 (q, OCH3), 61.9 (t, CH2OH), 69.4, 71.2, 71.3, 72.9, 75.2
(t, CH2CHRO(CH2CH2O)3), 80.2 (CHRO), 124.7, 125.0 (d, m-Ar), 132.4,
132.9, 135.2 (s, o-Ar), 144.5, 144.7 (s, p-Ar), 153.4, 155.6, 155.8 (s, i-Ar); MS
(CI, CH4): m/z (%): 865.1 (100) [MH] ; C55H76O8 (865.21): calcd C 76.35,
H 8.85; found C 76.24, H 8.97.
3
bpy-3-H), 8.65 (d, J 4.8 Hz, 1H; bpy-6'-H).
25,27-Dimethoxy-p-tert-butylcalix[4]arene-26,28-]2,10-bis(hydroxymethyl)]-
crown-5 (29a,b): Pure compounds 29a,b were obtained by column
chromatography on SiO2 with CHCl3/MeOH (10:1) as eluent. Yield
25,27-Dimethoxy-p-tert-butylcalix[4]arene-26,28-[2-(2,2'-bipyridine-6-
methyl)oxy-methyl]crown-5 (3): Preparative layer chromatography on
Al2O3 with CH2Cl2 as eluent gave compound 3 in a yield of 71%. An
analytically pure sample can be obtained by crystallization from CH3CN.
M.p. 182 ± 1848C; 1H NMR (300 MHz, CDCl3, 300 K): d 0.83, 0.86 (s, 9H;
1
64%; m.p. > 3008C; H NMR (400 MHz, CDCl3, 300 K): d 0.91 (s, 9H;
C(CH3)3), 1.00 (s, 9H; C(CH3)3), 1.22 (s, 9H; C(CH3)3), 1.32, 1.33 (s, 9H;
C(CH3)3), 2.07, 2.28 (brs, 2H; OH), 3.18 ± 3.27 (m, 4H; Heq), 3.59 ± 4.52 (m,
28H; ArCH2CHROCH2CH2, CHCH2OH, OCH3, Hax), 6.59 (brs, 2H;
CH3OAr-H), 6.72 (s, 2H; Ar-H), 6.97, 6.98 (s, 2H; Ar-H), 7.09, 7.10 (s, 2H;
Ar-H); 13C NMR (75.5 MHz, CDCl3, 300 K): d 31.1, 31.2, 31.6 (q,
C(CH3)3; t, ArCH2Ar), 33.6, 33.7, 34.0, 34.1 (s, C(CH3)3), 61.1, 61.6 (q,
OCH3), 61.5, 62.2 (t, CH2OH), 68.7, 69.7, 70.8, 71.2, 75.0, 75.2 (t,
ArOCH2CHROCH2CH2), 79.9, 80.4 (d, CHRO), 124.7, 124.9, 125.0,
125.2, 125.4 (d, m-Ar), 132.1, 132.8, 133.1, 134.4, 134.5, 135.3 (s, o-Ar),
144.4, 144.5, 144.8 (s, p-Ar), 153.4, 153.5, 155.2, 155.6, 156.1 (s, i-Ar); MS
2
C(CH3)3), 1.33 (s, 18H; C(CH3)3), 3.13 (d, J 13.2 Hz, 2H; Heq), 3.15 (d,
2J 13.4 Hz, 2H; Heq), 3.48 ± 4.42 (m, 27H; ArOCH2CHRO(CH2CH2O)3,
2
2
CHCH2, OCH3, Hax), 4.70 (d, J 13.5 Hz, 1H; OCHHbpy), 4.76 (d, J
13.5 Hz, 1H; OCHHbpy), 6.50 ± 6.54 (m, 4H; Ar-H), 7.09 (s, 2H; Ar-H),
7.10 (s, 2H; Ar-H), 7.27 (ddd, 3J 7.5 Hz, 3J 4.5 Hz, 4J 1.2 Hz, 1H; bpy-
5'-H), 7.42 (d, 3J 7.7 Hz, 1H; bpy-5-H), 7.74 (td, 3J 7.5 Hz, 4J 1.7 Hz,
1H; bpy-4'-H), 7.80 (dd, 3J 7.7 Hz, 3J 7.7 Hz, 1H; bpy-4-H), 8.27 (d, 3J
7.8 Hz, 1H; bpy-3'-H), 8.37 (d, 3J 7.8 Hz, 1H; bpy-3-H), 8.66 (d, 3J
4.5 Hz, 1H; bpy-6'-H); 13C NMR (75.5 MHz, CDCl3, 300 K): d 31.0 (t,
ArCH2Ar), 31.1, 31.7 (q, C(CH3)3), 33.6, 34.1 (s, C(CH3)3), 60.9, 61.3 (q,
OCH3), 69.8, 70.1, 70.9, 71.1, 71.2, 71.4, 72.9, 74.5, 75.6, 76.6 (t, ArCH2-
CHR(OCH2CH2)3), 77.4 (d, CHRO), 79.2 (t, CH2bpy), 119.7 (d, bpy-3),
121.2 (d, bpy-3'), 123.6, 124.5, 124.9, 125.0 (d, m-Ar, bpy-5, bpy-5'), 132.2,
132.6, 132.7, 132.9, 135.7, 135.8 (s, o-Ar), 136.8 (d, bpy-4'), 137.5 (d, bpy-4),
144.2, 144.3, 144.7 (s, p-Ar), 149.2 (d, bpy-6'), 155.5 (s, bpy-2ꢀ), 156.0, 156.2
(s, i-Ar, bpy-6), 157.9 (s, bpy-2); MS (CI, CH4): m/z (%): 1033.5 (100)
(CI, CH4): m/z (%): 895.6 (100) [MH] ; C56H78O9 (895.23): calcd C 75.13,
H 8.78; found C 75.04, H 8.85.
25,27-Dimethoxy-p-tert-butylcalix[4]arene-26,28-[2,10-bis(hydroxymethyl)]-
crown-5 (29c): Pure compound 29c was obtained by column chromatog-
raphy on SiO2 with CHCl3/MeOH (10:1) as eluent. Yield 65%; m.p. 290 ±
25
2928C; [a]
5.0 (c 0.0140, CHCl3); 1H NMR (300 MHz, CDCl3,
589
300 K): d 0.96 (s, 18H; C(CH3)3), 1.21 (s, 18H; C(CH3)3), 3.20 (d, 2J
12.7 Hz, 2H; Heq), 3.23 (d, 2J 12.7 Hz, 2H; Heq), 4.29 (d, 2J 13.0 Hz, 2H;
Hax), 4.34 (d, 2J 13.0, 2H; Hax), 3.61 ± 4.36 (m, 24H; ArOCH2-
CHROCH2CH2, CHCH2OH; OCH3), 6.70 (s, 4H; Ar-H), 6.96 (s, 4H;
Ar-H); 13C NMR (75.5 MHz, CDCl3, 300 K): d 31.2 and 31.6 (q,
C(CH3)3); t, ArCH2Ar), 33.7, 34.0 (s, C(CH3)3), 61.6, 62.2 (q, OCH3), 68.7,
70.8, 75.0 (OCH2CHROCH2CH2, CHCH2OH), 79.8 (CHRO), 124.9, 125.0,
125.2 (d, m-Ar), 132.8, 133.1, 134.1, 134.4 (s, o-Ar), 144.5, 144.8 (s, p-Ar),
153.5, 155.2 (s, i-Ar); C56H78O9 (895.23): calcd C 75.13, H 8.78; found C
75.01, H 8.71.
[MH] ; C66H84N2O8 (1033.40): calcd C 76.71, H 8.19, N 2.71; found C
76.81, H 8.24, N 2.75.
25,27-Dimethoxy-p-tert-butylcalix[4]arene-26,28-[2,10-bis(2,2'-bipyridine-
6-methyl)oxy-methyl]crown-4 (4):
Compounds 4a,b can be obtained from 29a,b in 62% yield after
preparative layer chromatography on Al2O3 with CH2Cl2/MeOH (99:1)
as eluent. The meso compound (4a) (Rf 0.26) can be separated from the
dl mixture (4b) (Rf 0.24) by preparative layer chromatography on Al2O3
with CH2Cl2 as eluent.
General procedure for the synthesis of 25,27-dimethoxy-p-tert-butylca-
lix[4]arene-26,28-[(2,2'-bipyridine-6-methyl)oxymethyl]crown-4 (2) and
-crown-5 (3), (4a,b), (4c): NaH (50% in mineral oil, 18 mg, 0.36 mmol
for compounds 27 and 28; or 36 mg, 0.66 mmol for compounds 29a,b and
29c) was added at RT to a stirred solution of calix[4]arene-hydromethyl-
crown 27, 28, 29a,b, or 29c (0.12 mmol) in dry THF (20 mL). After 15 min,
6-bromomethylbipyridine 30 (30.3 mg, 0.12 mmol for compounds 27 and
28; or 61 mg, 0.24 mmol for compounds 29a,b and 29c) was also added, and
meso-4a: 1H NMR (400 MHz, CDCl3, 253 K, cone): d 0.79 (s, 18H;
2
C(CH3)3), 1.33 (s, 18H; C(CH3)3), 3.13 (d, J 12.1 Hz, 2H; Heq), 3.16 (d,
2J 12.0 Hz, 2H; Heq), 3.46 ± 3.78 (m, 16H; ArOCH2CHROCH2CH2,
CHCH2O), 4.02 (s, 3H; OCH3), 4.19 (s, 3H; OCH3), 4.22 ± 4.35 (m, 2H;
CHRO), 4.31 (d, 2J 11.8 Hz, 2H; Hax), 4.41 (d, 2J 12.3 Hz, 2H; Hax), 4.69
(d, 2J 13.8 Hz, 2H; OCHHbpy), 4.83 (d, 2J 13.8 Hz, 2H; OCHHbpy),
6.46 (s, 2H; Ar-H), 6.47 (s, 2H; Ar-H), 7.14 (s, 2H; Ar-H), 7.15 (s, 2H; Ar-
H), 7.34 (dd, 3J 8.6 Hz, 3J 4.7 Hz, 2H; bpy-5'-H), 7.43 (d, 3J 7.8 Hz,
Chem. Eur. J. 2000, 6, No. 6
ꢁ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2000
0947-6539/00/0606-1033 $ 17.50+.50/0
1033